Skip to main content

Day: May 23, 2023

Datasea Announces New 5G Messaging Recharge Service Agreement

BEIJING, May 23, 2023 (GLOBE NEWSWIRE) — Datasea Inc., (NASDAQ: DTSS) (“Datasea” or the “Company”), incorporated in Nevada on September 2014, is a digital technology corporation engaged in three converging and innovative business segments: 5G messaging, acoustic intelligence, and digital smart city technology in China. Today, the Company is pleased to announce that Shuhai Jingwei Technology Co., Ltd. (“Shuhai Jingwei”), a subsidiary of the Chinese operating company contractually controlled by the Company, has entered into a 5G Messaging Recharge Service Agreement with Quanzhen Hulian Technology (Shenzhen) Co. Ltd. (“Quanzhen Hulian”).    Quanzhen Hulian, is an avant-garde service enterprise and serves its clients from multifarious sectors, encompassing new media, smart education,...

Continue reading

CMUV Bancorp Announces 2nd Quarter 2023 Cash Dividend

EL CENTRO, CA, May 23, 2023 (GLOBE NEWSWIRE) — via NewMediaWire – The Board of Directors of CMUV Bancorp, the bank holding company for Community Valley Bank, has approved a $0.10 Second Quarter cash dividend per common share.  The dividend will be payable on June 30, 2023 to all shareholders of record on June 8, 2023. Contact: Jon A. Edney, President/CEOPhone (760) 352-1889, mediarelations@yourcvb.com

Continue reading

T2 Biosystems Announces First Quarter 2023 Financial Results

Filed FDA submission for T2Biothreat Panel, implemented a restructuring program and announced exploration of strategic alternatives LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO) (the “Company”), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced financial results for the first quarter ended March 31, 2023. Recent Financial and Operational HighlightsAchieved first quarter total revenue of $2.1 million, including sepsis and related product revenue of $1.7 million and research contribution revenue of $0.4 million. Increased sepsis panel revenue by 11% year over year, driven by increased T2Bacteria® Panel sales of 109% in the U.S. and 55% globally. Executed contracts for 5 T2Dx® Instruments during the first quarter. Secured multi-year...

Continue reading

Luxury Car Rental Market [2022-2029] Size Worth USD 65.42 Billion in 2029 | Changing Preference to Luxury Automobile Manufacturers to Propel Market Development

Luxury Car Rental Market is Estimated to Surge at 7.5% During Forecast Period | Luxury Car Rental Market to Grow Progressively Pune, India, May 23, 2023 (GLOBE NEWSWIRE) — The global luxury car rental market size was valued at USD 29.95 billion in 2021 and is expected to reach the valuation of USD 39.54 billion in 2022. The market is expected to reach USD 65.42 billion by 2029 with a CAGR of 7.5% during the forecast period. Change in the preference for luxury cars from normal cars is anticipated to witness a positive market progress. Increasing brand awareness of luxury automobile manufacturers is estimated to propel market trajectory. Growing demand for demand-responsive vehicles is expected to aid market development. Fortune Business Insights™ shares this information in its report titled “Luxury Car Rental Market, 2022-2029. Luxury...

Continue reading

CohBar, Inc. and Morphogenesis, Inc. Enter into Definitive Merger Agreement to Advance an Innovative Late-stage Clinical Immuno-oncology Pipeline of Therapies to Overcome Resistance to Cancer Immunotherapy

Combined company will operate under the name “TuHURA Biosciences, Inc.” and advance a personalized cancer vaccine platform and preclinical tumor microenvironment modulators Lead asset, IFx-Hu2.0, expected to enter Phase 2/3 registration trial as first-line treatment for Merkel Cell Carcinoma in early 2024 $15 million PIPE financing to close concurrent with the closing of the proposed merger – combined company expected to have cash runway through 2024 Companies to hold a joint conference call and webcast today, Tuesday, May 23rd at 8:30 AM ETMENLO PARK, Calif. and TAMPA, Fla. , May 23, 2023 (GLOBE NEWSWIRE) — CohBar, Inc. (NASDAQ: CWBR) (“CohBar” or the “company”) and Morphogenesis, Inc. (“Morphogenesis”), a privately-held Phase 2/3 clinical-stage biotechnology company developing novel personalized cancer vaccines and tumor microenvironment...

Continue reading

OneRail and Quadient Partner to Provide Faster and Frictionless Delivery Solutions

OneRail logo OneRailParcel Pending by Quadient smart lockers incorporated into OneRail’s Omnichannel ecosystem for added operational efficiencyParis OneRail, a leading provider of solutions in last mile omnichannel fulfillment, and Quadient (Euronext Paris: QDT), a major global parcel locker operator, today announced a partnership to provide smart lockers as part of an omnichannel solution for a fast and seamless delivery experience. Integrated with OneRail’s Omnipoint platform, the Parcel Pending by Quadient smart locker system can be seamlessly incorporated into the existing order fulfillment process of retailers, enabling them to offer efficient and reliable delivery options to their customers and greater flexibility for delivery drivers to quickly pick up products, no matter the size, all while maintaining the visual integrity...

Continue reading

DZS Xtreme Slice Management Function Now Available as a Vendor-Validated, Containerized Network Service on Red Hat OpenShift

Unique, end-to-end 5G slice management and orchestration network function for Red Hat OpenShift helps operators efficiently monetize services while improving subscriber experience DALLAS, May 23, 2023 (GLOBE NEWSWIRE) — DZS (Nasdaq: DZSI), a global leader of access, optical and cloud-controlled software defined solutions, today announced that its DZS Xtreme Slice Management Function is now available as a cloud-native network function (CNF) in the Red Hat Ecosystem Catalog. As a vendor-validated solution on Red Hat OpenShift, DZS Xtreme Slice Management Function provides end-to-end slice and resource orchestration across the 5G Stand-Alone Core, RAN and transport domains of a 5G mobile network. Service providers can leverage this DZS Cloud solution to automate service enablement and life cycle operations to monetize a diverse array...

Continue reading

ABM to Announce Second Quarter 2023 Financial Results

Conference Call to be Held on June 6, 2023, at 8:30 AM (ET) NEW YORK, May 23, 2023 (GLOBE NEWSWIRE) — ABM (NYSE: ABM), a leading provider of facility solutions, today announced that it will release its earnings results for the Company’s fiscal second quarter 2023 on Tuesday, June 6, 2023, before market open. ABM will host its quarterly conference call for all interested parties on Tuesday, June 6, 2023, at 8:30 AM (ET). The live conference call can be accessed via audio webcast at the ‘Investors’ section of the Company’s website, located at www.abm.com, or by dialing (877) 451-6152 (domestic) or (201) 389-0879 (international) approximately 15 minutes prior to the scheduled time. A supplemental presentation will accompany the webcast on the Company’s website. A replay will be available approximately three hours after the webcast...

Continue reading

electroCore to Participate at 13th Annual LD Micro Invitational XIII

ROCKAWAY, N.J., May 23, 2023 (GLOBE NEWSWIRE) — electroCore, Inc. (the “Company”), (NASDAQ: ECOR) a commercial-stage bioelectronic medicine and wellness company, today announced that electroCore’s Chief Executive Officer, Dan Goldberger, will present at the 13th Annual LD Micro Invitational XIII in Los Angeles, California from June 6-8, 2023. LD Micro Invitational XIII:Date: Tuesday, June 6, 2023 Time: 11:00 AM PTEvent: PresentationVirtual viewers: Livestream For more information regarding the Invitational and to register to watch the presentation live, please visit the conference page here. About electroCore, Inc.electroCore, Inc. is a commercial stage bioelectronic medicine and wellness company dedicated to improving health through its non-invasive vagus nerve stimulation (“nVNS”) technology platform. Our focus is the commercialization...

Continue reading

T2 Biosystems Announces FDA 510(k) Submission for the T2Biothreat Panel

The T2Biothreat Panel detects six biothreat pathogens and runs on the FDA-cleared T2Dx Instrument LEXINGTON, Mass., May 23, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced that it has submitted a 510(k) premarket notification to the U.S. Food and Drug Administration (FDA) for the Company’s T2Biothreat™ Panel. The FDA submission follows the recently completed U.S. clinical evaluation that demonstrated very high sensitivity and specificity, and included 350 contrived positive samples and over 470 negative blood samples from both healthy and febrile subjects. The T2Biothreat Panel is a fully-automated, direct-from-blood test designed to run on the FDA-cleared T2Dx® Instrument and simultaneously detects six...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.